February 2020

Lapses in Compliance – Overcoming the Risks of Cost Cutting for OTC Drug Manufacturers

Is cost-cutting affecting compliance? Maxine Fritz discusses how lack of regulation in the OTC industry has led to manufacturer cost cutting and lapses in GMP compliance. Find out how OTC manufacturers can overcome these challenges to ensure they meet all relevant regulatory requirements.